INTERPACE BIOSCIENCES, INC. 10-K Cybersecurity GRC - 2024-04-01

Page last updated on July 16, 2024

INTERPACE BIOSCIENCES, INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-04-01 17:01:09 EDT.

Filings

10-K filed on 2024-04-01

INTERPACE BIOSCIENCES, INC. filed a 10-K at 2024-04-01 17:01:09 EDT
Accession Number: 0001493152-24-012464

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

ITEM 1C. CYBERSECURITY Cyber Risk Management and Strategy We have developed and maintain processes designed to assess, identify, and manage cybersecurity risks from potential unauthorized occurrences on or through our information technology systems that may result in adverse effects on the confidentiality, integrity, and availability of these systems and the data residing therein. The scope of these processes includes risks that may be associated with both our internally managed information technology (“IT”) systems and key business functions and sensitive data operated or managed by or maintained at third-party service providers. These processes are managed and monitored by a dedicated information technology team, which is led by our head of IT, and include mechanisms, controls, technologies, systems, and other processes designed to prevent or mitigate data loss, theft, misuse, or other security incidents or vulnerabilities affecting the data and maintain a stable information technology environment. We constantly monitor our information technology environment for abnormal behavior, conduct penetration and vulnerability testing, data recovery testing, security audits, and ongoing risk assessments, including due diligence on our key technology vendors and other third party service providers that have access to the personal information we collect, use, store, and transmit. We also conduct periodic employee trainings on cyber and information security, among other topics. We leverage standard industry tools from a software and hardware perspective and maintain a cybersecurity risk insurance policy. We consider cybersecurity, along with other significant risks that we face, within our overall enterprise risk management framework. In the last fiscal year, we have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents, which have materially affected us, but we face certain ongoing cybersecurity risks threats that, if realized, are reasonably likely to materially affect us. Governance Related to Cybersecurity Risks The Board of Directors, as a whole and at the committee level, has oversight for the most significant risks facing us and for our processes to identify, prioritize, assess, manage, and mitigate those risks. The Compliance Committee, which is comprised solely of independent directors, has been designated by our Board to oversee cybersecurity risks. The Compliance Committee receives periodic updates on cybersecurity and information technology matters and related risk exposures. The Board also receives updates from management and the Compliance Committee on cybersecurity risks on at least an annual basis. Our Vice President of Information Technology has over 10 years of experience managing information technology and cybersecurity matters. The Vice President of Information Technology, together with our senior leadership team, are responsible for assessing and managing cybersecurity risks and they work collaboratively across our company to implement policies and procedures designed to protect our information and systems from cybersecurity threats and to respond promptly to any material cybersecurity incidents in accordance with our incident response plans. A cross-functional team is responsible for responding to cybersecurity incidents.


Company Information

NameINTERPACE BIOSCIENCES, INC.
CIK0001054102
SIC DescriptionSurgical & Medical Instruments & Apparatus
TickerIDXG - OTC
Website
CategoryNon-accelerated filer
Smaller reporting company
Fiscal Year EndDecember 30